Article
Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis
3 Nov 2020
Abstract excerpt
To the Editor: Nowadays, many methods have been taken in early diagnosis and clinical therapy, but the overall survival (OS) of hepatocellular carcinoma (HCC) patients remains unsatisfactory.[1] Therefore, it is seriously significant to identify novel prognostic biomarkers and better to find the promising therapeutic targets. Proliferating cell nuclear antigen (PCNA) is a protein with molecular weight of 36,000...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
